India will review claims of AstraZeneca vaccine causing blood clots in 'unusual' sites
There have been no reports of cases in India, authorities are still looking into claims as many countries have either stopped or limited the use of the vaccine.
AstraZeneca's Britain COVID-19 vaccine clinical trials for children paused due to blood clot concerns
Britain and the vaccine's developers had until now resisted any restrictions in its use, saying that there was no proof of any link.
Researchers are hatching a new low-cost COVID-19 vaccine in chicken eggs
If NDV-HXP-S proves safe and effective, flu vaccine manufacturers could potentially produce well over a billion doses of it a year.
Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO
Like anti-malaria drug hydroxychloroquine — so far unproven by clinical trials — ivermectin is widely available and cheap.
Moderna to begin COVID-19 vaccine trials for children under the age of 12
The benefits of vaccinating children are direct like preventing rare serious pediatric Covid-19 and MIS-C but also indirect like limiting spread.
South Africa's COVID-19 vaccine trials saved the world from another long year of surprises
the trial in South Africa underscored the need to stamp out the virus before it mutates further.
Bharat Biotech’s intranasal vaccine for COVID-19: Everything we know so far about BBV154
The intranasal vaccine BBV154 is being tested to check if it prevents infection, halts person-to-person transmission, and progression of COVID-19.
TATA, CSIR in talks with Moderna to conduct trials, bring COVID-19 vaccine to India
Moderna's vaccine is based on mRNA technology and it 94 percent effective at preventing COVID-19 in people who were given two doses and had no history of the infection.
Johnson and Johnson expects COVID-19 vaccine results soon but lags behind in production
In 2021, Johnson & Johnson promised to supply 200 million doses to Covax and will supply another 300 million to Covax in 2022.
AIPSN urges govt to reconsider emergency approval for Covaxin till Phase 3 data is published
Either pausing or cancelling approvals is not unheard of, and the CDSCO does have the authority to do so.
Chinese COVID-19 vaccine CoronaVac shows 78 percent efficacy in Phase 3 trials in Brazil
Turkey, which also helped carry out CoronaVac's Phase 3 tests, said the vaccine had shown the effectiveness of 91.25 percent in its trials.
Caught in deadly race with new COVID strain, Britain 'gambles' with mix-and-match vaccine regimen
Scientists have slammed the new guidance which allows for the interchange of vaccines, if the second dose of the vaccine originally received is not available, saying officials have abandoned science and are just trying to 'guess their way out of a mess'
As more COVID-19 vaccines get approval, experts debate if it's time for trial volunteers to get the real thing
In an ideal world, vaccine trial participants could hold off to discover whether they received the dummy shot or the vaccine. But experts agree the current circumstances are extraordinary
Oral antiviral drug Molnupiravir can block spread of SARS-CoV-2 virus in ferrets, study shows
Molnupiravir is now in the advanced phase, multi-centre, clinical II/III trials in human beings after successful completion of phase I safety trials.
India doesn't need Pfizer COVID-19 shot; vaccine should be available by Feb-March: Harsh Vardhan
The health minster said that no state will be given preferential treatment and the distribution of vaccines will be equitable.
Oxford vaccine candidate found safe in elderly, offered immunity against SARS-CoV-2 in all age groups
Two weeks after volunteers were administered a second dose, over 99 percent of them had neutralising antibody responses regardless of age.
What are monoclonal antibodies ? Why do we need them as well as a COVID-19 vaccine?
The FDA issued emergency use authorization for Eli Lilly’s monoclonal antibody while Regeneron is still awaiting the FDA’s green light for its antibody treatment.
Volunteers to be exposed to COVID-19 virus to find the amount of virus it take to infect a person
The volunteer would be infected via the nose and the results will be used to study how vaccines might work and to explore potential treatments.
DCGI approves Dr Reddy's request to conduct Phase 2, 3 clinical trials with Russia's Sputnik V COVD-19 vaccine
RDIF will also supply 100 million doses of Dr Reddy's after receiving Indian regulatory approval.
Why even vital medicines, vaccines are rarely tested for safety in pregnant women
For decades, expecting mothers have been considered a vulnerable group, for the potential harm to their fetuses’ health.